Recent Finacing
Recent Raise
TAE Life Sciences develops accelerator-based neutron beam systems and proprietary boron-10 target drugs for BNCT, operates drug development labs in Santa Monica and partners for clinical installations.
Focus Areas
Recent Investors
Total Raised
Funding rounds
Investor
See the team members at TAE Life Sciences.
